IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.120
-0.030 (-2.61%)
May 14, 2025, 10:13 AM - Market open
IGM Biosciences Employees
IGM Biosciences had 149 employees as of December 31, 2024. The number of employees decreased by 75 or -33.48% compared to the previous year.
Employees
149
Change (1Y)
-75
Growth (1Y)
-33.48%
Revenue / Employee
$17,993
Profits / Employee
-$1,334,705
Market Cap
66.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IGMS News
- 4 months ago - IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - Market Watch
- 4 months ago - IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs - GlobeNewsWire
- 6 months ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 8 months ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 8 months ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons
- 8 months ago - IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga